OMICUnknown
Singular Genomics Systems, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Singular Genomics Systems, Inc. (OMIC), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are OMIC insiders buying or selling?
Singular Genomics Systems, Inc. insiders reported no open-market purchases or sales in the last 12 months. Since June 2021, Trabud has recorded 12 Form 4 filings for OMIC: 7 buys ($35.3M) and 5 sells ($399.4K).
Source: SEC EDGAR Form 4
Key Statistics (June 2021 – Feb 14, 2025)
Total Form 4 filings
12
SEC EDGAR
Insider filers
6
Insider buys (7)
$35.3M
Insider sells (5)
$399.4K
Insider sentiment
Net buyingNet insider flow of $34.9M in net buying since June 2021.
Recent OMIC insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Feb 14, 2025 | Spaventa Andrew | Chief Executive Officer | Sale | 800 | $19.89 | $15.9K | SEC ↗ |
| Dec 17, 2024 | Spaventa Andrew | Chief Executive Officer | Sale | 180 | $20.16 | $3.6K | SEC ↗ |
| Nov 13, 2024 | Spaventa Andrew | Chief Executive Officer | Sale | 695 | $22.55 | $15.7K | SEC ↗ |
| Sep 18, 2024 | Kevin Tang | 10% Owner | Purchase | 122.4K | $14.75 | $1.8M | SEC ↗ |
| Sep 17, 2024 | Spaventa Andrew | Chief Executive Officer | Sale | 175 | $12.38 | $2.2K | SEC ↗ |
| Nov 20, 2023 | Spaventa Andrew | Chief Executive Officer | Purchase | 118.5K | $0.42 | $49.6K | SEC ↗ |
| Nov 20, 2023 | Glezer Eli N. | Chief Scientific Officer | Purchase | 200.0K | $0.43 | $85.6K | SEC ↗ |
| Aug 15, 2023 | Kim P. Kamdar | Director | Sale | 631.6K | $0.57 | $362.0K | SEC ↗ |
| May 19, 2023 | Glezer Eli N. | Chief Scientific Officer | Purchase | 170.0K | $0.82 | $138.9K | SEC ↗ |
| Dec 13, 2022 | Glezer Eli N. | Chief Scientific Officer | Purchase | 50.0K | $2.00 | $100.0K | SEC ↗ |
| May 19, 2022 | Michael J Pellini | Director | Purchase | 26.8K | $3.30 | $88.6K | SEC ↗ |
| Jun 3, 2021 | Flynn James E | Other, 10% Owner | Purchase | 1.5M | $22.00 | $33.0M | SEC ↗ |
Showing the 12 most recent of 12 Form 4 filings for Singular Genomics Systems, Inc..
Most active OMIC insiders
- Spaventa Andrew5 filings
- Glezer Eli N.3 filings
- Flynn James E1 filing
- Kevin Tang1 filing
- Kim P. Kamdar1 filing
Ask anything about OMIC insider activity
Use Trabud's AI agent to query Singular Genomics Systems, Inc.'s Form 4 history in plain English — "Show me OMIC CEO purchases this year" or compare it against any other ticker.
Open the AI agentOMIC insider trading FAQ
Are Singular Genomics Systems, Inc. insiders buying or selling?
Singular Genomics Systems, Inc. insiders reported no open-market purchases or sales in the last 12 months. Since June 2021, Trabud has recorded 12 Form 4 filings for OMIC: 7 buys ($35.3M) and 5 sells ($399.4K). Over the full record that is net buying of $34.9M.
How many insiders trade OMIC stock?
6 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Singular Genomics Systems, Inc.. The most recent filing was accepted on Feb 14, 2025.
Where does Trabud get OMIC insider trading data?
All OMIC insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.